Epstein-Barr virus-dependent lymphoproliferative disease

Critical role of IL-6

Sandrine Mauray, Marie Thérèse Fuzzati-Armentero, Philippe Trouillet, Marlies Rüegg, Grazia Nicoloso, Margreet Hart, Lucien Aarden, Marc Schapira, Michel A. Duchosal

Research output: Contribution to journalArticle

33 Citations (Scopus)

Abstract

Epstein-Barr virus (EBV)-induced lymphoproliferative disease (lpd) is a B cell neoplasm that affects patients who are immunosuppressed in the context of organ transplantation or HIV infection. A model for the aggressive form of this entity was generated by xenotransplantation of SCID mice with human peripheral blood leukocytes from individuals with prior contact with EBV. This model, where large B cell lymphoma occurs, was used to test the hypothesis that IL-6 has a major role in EBV-induced B cell tumorigenesis. IL-6 is known to differentiate B cells into immunoglobulin-secreting plasma cells and induce EBV replication, and xenochimeric animals have detectable serum levels of human IL-6. Human IL-6 inhibition with a neutralizing monoclonal antibody decreased tumor incidence from 62% to 27%. In addition, anti-IL-6 treatment significantly improved xenotransplanted animal survival, with median survival at > 245 days when compared to that of controls at 132 days. In conclusion, IL-6 plays a critical role in the pathogenesis of EBV-induced human lpd, and IL-6 inhibition may represent a new and promising preventive or therapeutic approach against this malignancy.

Original languageEnglish
Pages (from-to)2065-2073
Number of pages9
JournalEuropean Journal of Immunology
Volume30
Issue number7
DOIs
Publication statusPublished - 2000

Fingerprint

Human Herpesvirus 4
Interleukin-6
B-Lymphocytes
Antibody-Producing Cells
Neoplasms
Heterologous Transplantation
SCID Mice
Organ Transplantation
B-Cell Lymphoma
Virus Replication
Plasma Cells
Neutralizing Antibodies
HIV Infections
Carcinogenesis
Leukocytes
Monoclonal Antibodies
Survival
Incidence
Therapeutics
Serum

Keywords

  • Epstein-Barr virus
  • IL-6
  • Lymphoproliferative disease
  • SCID mouse
  • Xenotransplantation

ASJC Scopus subject areas

  • Immunology

Cite this

Mauray, S., Fuzzati-Armentero, M. T., Trouillet, P., Rüegg, M., Nicoloso, G., Hart, M., ... Duchosal, M. A. (2000). Epstein-Barr virus-dependent lymphoproliferative disease: Critical role of IL-6. European Journal of Immunology, 30(7), 2065-2073. https://doi.org/10.1002/1521-4141(200007)30:7<2065::AID-IMMU2065>3.0.CO;2-W

Epstein-Barr virus-dependent lymphoproliferative disease : Critical role of IL-6. / Mauray, Sandrine; Fuzzati-Armentero, Marie Thérèse; Trouillet, Philippe; Rüegg, Marlies; Nicoloso, Grazia; Hart, Margreet; Aarden, Lucien; Schapira, Marc; Duchosal, Michel A.

In: European Journal of Immunology, Vol. 30, No. 7, 2000, p. 2065-2073.

Research output: Contribution to journalArticle

Mauray, S, Fuzzati-Armentero, MT, Trouillet, P, Rüegg, M, Nicoloso, G, Hart, M, Aarden, L, Schapira, M & Duchosal, MA 2000, 'Epstein-Barr virus-dependent lymphoproliferative disease: Critical role of IL-6', European Journal of Immunology, vol. 30, no. 7, pp. 2065-2073. https://doi.org/10.1002/1521-4141(200007)30:7<2065::AID-IMMU2065>3.0.CO;2-W
Mauray, Sandrine ; Fuzzati-Armentero, Marie Thérèse ; Trouillet, Philippe ; Rüegg, Marlies ; Nicoloso, Grazia ; Hart, Margreet ; Aarden, Lucien ; Schapira, Marc ; Duchosal, Michel A. / Epstein-Barr virus-dependent lymphoproliferative disease : Critical role of IL-6. In: European Journal of Immunology. 2000 ; Vol. 30, No. 7. pp. 2065-2073.
@article{4c5bcf4fdbf24d659a9080097b494a22,
title = "Epstein-Barr virus-dependent lymphoproliferative disease: Critical role of IL-6",
abstract = "Epstein-Barr virus (EBV)-induced lymphoproliferative disease (lpd) is a B cell neoplasm that affects patients who are immunosuppressed in the context of organ transplantation or HIV infection. A model for the aggressive form of this entity was generated by xenotransplantation of SCID mice with human peripheral blood leukocytes from individuals with prior contact with EBV. This model, where large B cell lymphoma occurs, was used to test the hypothesis that IL-6 has a major role in EBV-induced B cell tumorigenesis. IL-6 is known to differentiate B cells into immunoglobulin-secreting plasma cells and induce EBV replication, and xenochimeric animals have detectable serum levels of human IL-6. Human IL-6 inhibition with a neutralizing monoclonal antibody decreased tumor incidence from 62{\%} to 27{\%}. In addition, anti-IL-6 treatment significantly improved xenotransplanted animal survival, with median survival at > 245 days when compared to that of controls at 132 days. In conclusion, IL-6 plays a critical role in the pathogenesis of EBV-induced human lpd, and IL-6 inhibition may represent a new and promising preventive or therapeutic approach against this malignancy.",
keywords = "Epstein-Barr virus, IL-6, Lymphoproliferative disease, SCID mouse, Xenotransplantation",
author = "Sandrine Mauray and Fuzzati-Armentero, {Marie Th{\'e}r{\`e}se} and Philippe Trouillet and Marlies R{\"u}egg and Grazia Nicoloso and Margreet Hart and Lucien Aarden and Marc Schapira and Duchosal, {Michel A.}",
year = "2000",
doi = "10.1002/1521-4141(200007)30:7<2065::AID-IMMU2065>3.0.CO;2-W",
language = "English",
volume = "30",
pages = "2065--2073",
journal = "European Journal of Immunology",
issn = "0014-2980",
publisher = "wiley",
number = "7",

}

TY - JOUR

T1 - Epstein-Barr virus-dependent lymphoproliferative disease

T2 - Critical role of IL-6

AU - Mauray, Sandrine

AU - Fuzzati-Armentero, Marie Thérèse

AU - Trouillet, Philippe

AU - Rüegg, Marlies

AU - Nicoloso, Grazia

AU - Hart, Margreet

AU - Aarden, Lucien

AU - Schapira, Marc

AU - Duchosal, Michel A.

PY - 2000

Y1 - 2000

N2 - Epstein-Barr virus (EBV)-induced lymphoproliferative disease (lpd) is a B cell neoplasm that affects patients who are immunosuppressed in the context of organ transplantation or HIV infection. A model for the aggressive form of this entity was generated by xenotransplantation of SCID mice with human peripheral blood leukocytes from individuals with prior contact with EBV. This model, where large B cell lymphoma occurs, was used to test the hypothesis that IL-6 has a major role in EBV-induced B cell tumorigenesis. IL-6 is known to differentiate B cells into immunoglobulin-secreting plasma cells and induce EBV replication, and xenochimeric animals have detectable serum levels of human IL-6. Human IL-6 inhibition with a neutralizing monoclonal antibody decreased tumor incidence from 62% to 27%. In addition, anti-IL-6 treatment significantly improved xenotransplanted animal survival, with median survival at > 245 days when compared to that of controls at 132 days. In conclusion, IL-6 plays a critical role in the pathogenesis of EBV-induced human lpd, and IL-6 inhibition may represent a new and promising preventive or therapeutic approach against this malignancy.

AB - Epstein-Barr virus (EBV)-induced lymphoproliferative disease (lpd) is a B cell neoplasm that affects patients who are immunosuppressed in the context of organ transplantation or HIV infection. A model for the aggressive form of this entity was generated by xenotransplantation of SCID mice with human peripheral blood leukocytes from individuals with prior contact with EBV. This model, where large B cell lymphoma occurs, was used to test the hypothesis that IL-6 has a major role in EBV-induced B cell tumorigenesis. IL-6 is known to differentiate B cells into immunoglobulin-secreting plasma cells and induce EBV replication, and xenochimeric animals have detectable serum levels of human IL-6. Human IL-6 inhibition with a neutralizing monoclonal antibody decreased tumor incidence from 62% to 27%. In addition, anti-IL-6 treatment significantly improved xenotransplanted animal survival, with median survival at > 245 days when compared to that of controls at 132 days. In conclusion, IL-6 plays a critical role in the pathogenesis of EBV-induced human lpd, and IL-6 inhibition may represent a new and promising preventive or therapeutic approach against this malignancy.

KW - Epstein-Barr virus

KW - IL-6

KW - Lymphoproliferative disease

KW - SCID mouse

KW - Xenotransplantation

UR - http://www.scopus.com/inward/record.url?scp=0033949938&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033949938&partnerID=8YFLogxK

U2 - 10.1002/1521-4141(200007)30:7<2065::AID-IMMU2065>3.0.CO;2-W

DO - 10.1002/1521-4141(200007)30:7<2065::AID-IMMU2065>3.0.CO;2-W

M3 - Article

VL - 30

SP - 2065

EP - 2073

JO - European Journal of Immunology

JF - European Journal of Immunology

SN - 0014-2980

IS - 7

ER -